Sign in Subscribe

Provider Reform

Reforms to service pricing and reimbursement across hospital and retail settings—shaping how innovative medicines are adopted and accessed through key distribution channels in China.
Nov
08
China's Medical Service Pricing Reform: 3 Core Challenges

China's Medical Service Pricing Reform: 3 Core Challenges

China's medical service pricing reform is pivotal in reshaping China's healthcare landscape, impacting not only inpatient
4 min read
Aug
30
Improving Access to Innovative Drugs: Can China’s Dual-Channel Policy Deliver?

Improving Access to Innovative Drugs: Can China’s Dual-Channel Policy Deliver?

To tackle the hospital formulary access issues faced by some NRDL-negotiated drugs, the National Healthcare Security Administration (NHSA) introduced the
5 min read
Jul
05
Behind the Scenes: Exploring the Roadblocks to Formulary Listing for NRDL-Negotiated Drugs in China Public Hospitals

Behind the Scenes: Exploring the Roadblocks to Formulary Listing for NRDL-Negotiated Drugs in China Public Hospitals

China's National Reimbursement Drug List (NRDL) is increasingly incorporating innovative drugs. Once included in the NRDL, these drugs
6 min read
May
10
How China’s Provider Payment Reform Will Impact Key Healthcare Stakeholders

How China’s Provider Payment Reform Will Impact Key Healthcare Stakeholders

Our last article discussed the context behind the DRG/DIP payment reform and how China has adopted this dual-track payment
9 min read
May
03
Understanding China's Dual-Track DRG DIP Provider Payment Reform

Understanding China's Dual-Track DRG DIP Provider Payment Reform

China has undergone a significant transformation in its healthcare system in recent years. One central area of reform has been
6 min read